Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Evotec SE (EVT.DE)

XETRA - XETRA Delayed Price. Currency in EUR
Add to watchlist
35.83-1.57 (-4.20%)
At close: 05:35PM CET
Advertisement

Evotec SE

Essener Bogen 7
Hamburg 22419
Germany
49 40 560 81 0
https://www.evotec.com

Sector(s)Healthcare
IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees4,081

Key Executives

NameTitlePayExercisedYear Born
Dr. Werner Lanthaler M.B.A., MBA, MPA, Ph.D.Chairman of Management Board & CEO1.06MN/A1968
Mr. Enno SpillnerCFO & Member of Management Board608kN/A1970
Dr. Cord Dohrmann Ph.D.Chief Scientific Officer & Member of Management Board792kN/A1964
Dr. Craig JohnstoneCOO & Member of Management Board618kN/A1970
Ms. Anja BoslerPrincipal Accounting Officer and Sr. VP of Group AccountingN/AN/AN/A
Mr. Volker BraunSr. VP and Global Head of Investor Relations & ESGN/AN/AN/A
Dr. Christian DargelEVP Global Head of Legal & ComplianceN/AN/AN/A
Gabriele HansenSr. VP of Corp. Communications, Marketing & Investor RelationsN/AN/AN/A
Ms. Monika ConradtGlobal Head of HRN/AN/AN/A
Dr. Ian M. HunneyballSr. VP of Programme Management & Clinical OperationsN/AN/A1950
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

Evotec SE operates as a drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as neuronal diseases, diabetes and complications of diabetes, pain, inflammation, oncology, infectious diseases, respiratory diseases, fibrosis, rare diseases, and women's health. It has collaboration agreements with Bayer AG; Chinook Therapeutics; Novo Nordisk A/S; Galapagos; Pfizer Inc.; CONBA Pharmaceutical Co., Ltd.; Celgene; Kazia Therapeutics; Apeiron Biologics; and Takeda Pharmaceuticals. The company was formerly known as Evotec AG and changed its name to Evotec SE in April 2019. Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany.

Corporate Governance

Evotec SE’s ISS Governance QualityScore as of September 26, 2021 is 6. The pillar scores are Audit: 6; Board: 7; Shareholder Rights: 1; Compensation: 7.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement